250
Participants
Start Date
May 4, 2022
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
Salivary samples
"For patients with a benign ovarian cyst, 1 saliva sample taken at 3 times (concomitant with a visit performed in routine care):~* During the inclusion visit,~* At the postoperative visit,~* At the 6-month follow-up visit~For patients with ovarian cancer, 1 saliva sample taken at different times (concomitant with a visit performed in routine care):~* At the inclusion visit,~* During the postoperative visit,~* At the follow-up visits (6 months post-surgery and then every 6 months until 24 months)~For patients with a borderline ovarian tumor, 1 saliva sample taken at different times (concomitant with a visit performed in routine care):~* At the inclusion visit,~* During the postoperative visit,~* During pre- and post-chemotherapy visits (before and after each cycle)~* During follow-up visits (every 4 months until 24 months)"
RECRUITING
CHU de Caen, Caen
RECRUITING
CH Bastia, Bastia
RECRUITING
CHU Rennes, Rennes
RECRUITING
CHRU Bretonneau-Tours, Tours
RECRUITING
CHU Angers, Angers
RECRUITING
CHU Lyon Sud / Hospices Civils de Lyon, Lyon
RECRUITING
CHU Tenon, Paris
RECRUITING
CH Niort, Niort
RECRUITING
Centre Antoine Lacassagne, Nice
RECRUITING
Clinique La sagesse, Rennes
RECRUITING
CHU Rouen, Hôpital de Bois-Guillaume, Rouen
RECRUITING
Clinique Pasteur, Toulouse
Lead Sponsor
Monitoring Force Group
INDUSTRY
iGenSeq
UNKNOWN
ZIWIG
INDUSTRY